跳至主要内容
临床试验/jRCT1071230073
jRCT1071230073招募中不适用

The influence of remimazolam on the reversal of rocuronium-induced neuromuscular blockade with sugammadex

未提供0 个研究点目标入组 30 人开始时间: 2023年10月31日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
30
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Treatment Purpose
盲法
Single Blind

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • Patients over 18 years old scheduled for elective surgery under general anesthesia. All patients were American Society of Anesthesiologists physical status class I or II.

排除标准

  • Patients under 18 years old, emergency surgery, obesity (BMI 30 kg/m2 and more), with hepatic and renal dysfunction, with neuromuscular disorder, with contraindication to benzodiazepine

结局指标

主要结局

-

Time from sugamadex administration to TOF ratio 0.90 and more

次要结局

  • Time from initial rocuronium administration to TOF count 0
  • Time from initial rocuronium administration to reappearance of T1 and T2
  • Total rocuronium dose used during the surgery(during the surgery)

研究者

发起方
未提供

相似试验